LATE EFFECTS OF CHILDHOOD CANCER: THE FOUNDATION FOR RISK-STRATIFIED PEDIATRIC CANCER CARE LONG TERM

Código QR

LATE EFFECTS OF CHILDHOOD CANCER: THE FOUNDATION FOR RISK-STRATIFIED PEDIATRIC CANCER CARE LONG TERM

Guardado en:

Detalles Bibliográficos
Autor principal:	Melissa M. Hudson
Formato:	article
Lenguaje:	EN
Publicado:	Elsevier 2021
Materias:	Diseases of the blood and blood-forming organs RC633-647.5
Acceso en línea:	https://doaj.org/article/74de3193359742269e65bf17c3d84d10
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

EVALUATION OF APPROPRIATE USE OF PEDIATRIC FRESH FROZEN PLASMA IN A TERTIARY CARE HOSPITAL
por: Dilek GURLEK GOKCEBAY, et al.
Publicado: (2021)

Multiple myeloma: optimal management and long-term disease control
por: Sriskandarajah P, et al.
Publicado: (2014)

PREDICTORS OF OUTCOME AND SURVIVAL IN PROSTATE CANCER – DATA FROM TERTIARY CARE UROLOGY INSTITUTE IN PAKISTAN
por: Syed Najeeb Niamatullah
Publicado: (2021)

CHILDHOOD IMMUNE THROMBOCYTOPENIA: A MULTICENTER QUESTIONNAIRE STUDY
por: Ayşegül Ünüvar, et al.
Publicado: (2021)

THE OUTCOME OF IMMUNE THROMBOCYTOPENIC PURPURA IN CHILDHOOD AND THE RISK FACTORS FOR CHRONICITY
por: Barış YILMAZ, et al.
Publicado: (2021)

INFLAMMATION AND CANCER
por: Jean-François Rossi
Publicado: (2021)

Long-term safety and efficacy of dasatinib in the treatment of chronic-phase chronic myeloid leukemia patients resistant or intolerant to imatinib
por: Shoumariyeh K, et al.
Publicado: (2014)

NEW ADVANCES IN PEDIATRIC ACUTE MYELOID LEUKEMIA
por: Özlem Tüfekçi
Publicado: (2021)

ACTINOMYCES ODONTOLYTICUS: A RARE CAUSE OF PEDIATRIC FEBRILE NEUTROPENIA
por: Meric KAYMAK CIHAN, et al.
Publicado: (2021)

PONATINIB EXPERIENCE IN A PEDIATRIC CHRONIC MYELOID LEUKEMIA PATIENT
por: Serap Karaman, et al.
Publicado: (2021)

UNUSUAL METABOLIC COMPLICATIONS OF CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA: HYPERCALCEMIA, HYPERAMONEMIA, LACTIC ASIDOSIS
por: Dilek Kaçar, et al.
Publicado: (2021)

AN APPROACH TO PAIN IN CHILDREN WITH CANCER
por: Yavuz Akçaboy
Publicado: (2021)

PRINCIPLES OF TRANSFUSION IN CHILDREN WITH CANCER
por: Dilek Gürlek Gökçebay
Publicado: (2021)

LEWIS C IN BREAST CANCER PROGRESSION
por: Нина Гадецкая
Publicado: (2021)

CHARACTERISTICS AND OUTCOME OF T(8;21)-POSITIVE CHILDHOOD ACUTE MYELOID LEUKEMIA: A SINGLE INSTITUTION'S EXPERIENCE
por: Volkan KÖSE, et al.
Publicado: (2021)

CONSTITUTIONAL MISSMATCH DEFECT REPAIR DISORDER (CMMRD) IN PEDIATRIC HIGH GRADE GLIOMA
por: Bahattin Tanrıkulu, et al.
Publicado: (2021)

ANTI-GLYCAN ANTIBODIES IN THE DIAGNOSIS OF GASTRIC CANCER
por: Nadezhda Shilova, et al.
Publicado: (2021)

THE EFFECT OF NIVOLUMAB IN PEDIATRIC MALIGNANT TUMORS: A SINGLE CENTER EXPERIENCE WITH EIGHT PATIENTS
por: Veysel GOK, et al.
Publicado: (2021)

Bone marrow involvement in small cell lung cancer
por: Giuseppe G. Loscocco, et al.
Publicado: (2021)

NECESSITY FOR A CUSTOMIZED NGS PANEL FOR ACCURATE DIAGNOSIS AND TARGETED THERAPIES IN PEDIATRIC GLIAL TUMORS
por: Ayça Erşen Danyeli, et al.
Publicado: (2021)

A CHALLENGE IN PEDIATRIC ACUTE LEUKEMIA TREATMENT: UNEXPECTED, PROLONGED CYTOPENIA. IS IT BE CALLLED ‘INCOMPLETE HLH’?
por: Ersin Toret, et al.
Publicado: (2021)

IS METHYLATION STATUS SUBGROUPING REALLY A STRONG PROGNOSTIC FACTOR IN PEDIATRIC POSTERIOR FOSSA EPENDYMOMA?
por: Bahattin Tanrıkulu, et al.
Publicado: (2021)

LATE DIAGNOSIS OF CONGENITAL METHEMOGLOBINEMIA IN A 33-YEAR-OLD CYANOTIC PATIENT, CASE REPORT AND REVIEW OF LITERATURE
por: MAYA ALDEEB, et al.
Publicado: (2021)

HAEMOPHILIA AND NURSING CARE
por: Marcela Ganzella
Publicado: (2021)

A new era in blood and lymphatic cancer biology and therapy
por: David Dingli
Publicado: (2011)

SYNTHETIC BIOLOGY MEETS PRECISION MEDICINE: DRUG REPURPOSING FOR BLOOD CANCER PRECISION MEDICINE
por: Deepak Balaji Thimiri Govindaraj Thimiri Govindaraj
Publicado: (2021)

THE ROLE OF SUBPOPULATIONS OF MOBILIZED PERIPHERAL HEMATOPOIETIC STEM CELLS IN THE RESTORATION OF HEMATOPOIESIS DURING HIGH-DOSE CHEMOTHERAPY IN CANCER PATIENTS
por: Liudmila GRIVTSOVA, et al.
Publicado: (2021)

B1-CELLS OF INNATE IMMUNITY IN THE BONE MARROW IN BREAST CANCER PATIENTS: IDENTIFICATION AND THEIR RELATIONSHIP WITH CLINICAL AND MORPHOLOGICAL PARAMETERS
por: Svetlana Chulkova, et al.
Publicado: (2021)

Azacytidine Treatment for VEXAS Syndrome
por: Marc H. G. P. Raaijmakers, et al.
Publicado: (2021)

Trends in the treatment of cutaneous T-cell lymphoma &ndash; critical evaluation and perspectives on vorinostat
por: Zhang CL, et al.
Publicado: (2012)

MicroRNA dysregulation in B-cell non-Hodgkin lymphoma
por: Lim EL, et al.
Publicado: (2013)

Critical appraisal of belinostat in the management of T-cell lymphoma – patient considerations
por: Bodiford A, et al.
Publicado: (2015)

The expanding role of bendamustine in chronic lymphocytic leukemia
por: Nair KS, et al.
Publicado: (2015)

Bortezomib in autoimmune hemolytic anemia and beyond
por: Raffaella Pasquale, et al.
Publicado: (2021)

Life-Threatening Retroperitoneal Hematoma in a Patient with COVID-19
por: Monarch Shah, et al.
Publicado: (2021)

A method to determine if more than surrogate outcomes were improved: The EMR glitch experiment
por: Jennifer Gill, et al.
Publicado: (2020)

All bleeding matters … but the details may not
por: Sarah H. O’Brien
Publicado: (2020)

The Use of Etoposide, Ara-Cytarabine, and Melphalan (EAM) Conditioning Chemotherapy in Autologous Stem Cell Transplantation (ASCT) for a Patient with Relapsed Hodgkin’s Lymphoma
por: Eko A. Pangarsa, et al.
Publicado: (2021)

PP Transcon 2020 Abstracts Compilation
Publicado: (2021)

Positive/external control of rapid diagnostic tests: A step forward in malaria screening
por: Rasika D Setia, et al.
Publicado: (2021)